COMMUNIQUÉS West-GlobeNewswire
-
Xanamem proof-of-concept trial demonstrating anti-depressant activity published in the British Journal of Psychiatry
20/07/2026 -
Applied Biologics Announces Submission of XWRAP® Translational Research Abstract for Consideration at SAWC Fall 2026
20/07/2026 -
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
20/07/2026 -
Daré Bioscience Launches Nationwide Virtual Bus Tour Webinar Series to Showcase Commercial Strategy and Growth Opportunities
20/07/2026 -
TOMI Environmental and Carbonium Core Positioned To Play Key Role in The Onshoring of Essential Strategic Materials for Defense and Global Disinfection
20/07/2026 -
Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET
20/07/2026 -
CurePSP Awards Record Pathway and Pipeline Grants to Advance PSP and CBD Research
20/07/2026 -
Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
20/07/2026 -
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
20/07/2026 -
Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar
20/07/2026 -
ColestZen Official Launch 2026 - Natural Cholesterol Support Supplement for Adults (US, UK, Canada, and Australia)
20/07/2026 -
Vireo Growth Inc. to Acquire Certain Assets of The Cannabist Company Holdings Inc.
20/07/2026 -
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
20/07/2026 -
Nouscom Selected for Oral Presentation on NOUS-209 Re-treatment and Long-Term Follow-Up in Lynch Syndrome Carriers at ESMO Congress 2026
20/07/2026 -
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
20/07/2026 -
INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform
20/07/2026 -
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
20/07/2026 -
Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY
20/07/2026 -
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
20/07/2026
Pages